← back to search

Guadalupe Sabio

Universidad de Navarra · ES
Area of research
Epidemiology · Molecular Biology
Research interest
Research interests include Adipose Tissue and Metabolism, Liver Disease Diagnosis and Treatment, Adipokines, Inflammation, and Metabolic Diseases, and Melanoma and MAPK Pathways.
h-index
43
citations
7,142
works
156
NIH funding
primary concept
Medicine
email

Recent publications

Microglia Rank signaling regulates GnRH neuronal function and the hypothalamic-pituitary-gonadal axis.
2026cited by 0position: contributordoi
TUMOR–PRE-ADIPOCYTE CROSSTALK SUSTAINS BREAST CANCER GROWTH VIA RET SIGNALLING
2026cited by 0position: contributordoi
The aging modulator miR-29 is essential for adult cardiomyocyte function
2026cited by 0position: contributordoi
A hypothalamus-liver-skeletal muscle axis controlled by JNK1 and FGF21 mediates olanzapine-induced insulin resistance in an intraperitoneal treatment in male mice
2026cited by 0position: contributordoi
Inhibition of p107 alleviates liver steatosis by reducing de novo fatty acid synthesis
2026cited by 0position: contributordoi
Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis
Nature Communications 2025cited by 6position: lastdoi
Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis.
2025cited by 4position: contributordoi
Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity.
2025cited by 3position: contributordoi
Adipocyte MKK3 Increases in Human Obesity protecting against Insulin Resistance by p38β activation
2025cited by 0position: contributordoi
Author Reply to Peer Reviews of Loss of the alternative calcineurin variant CnAβ1 enhances brown adipocyte differentiation and drives metabolic overactivation through FoxO1 activation
2025cited by 0position: contributordoi
Loss of the alternative calcineurin variant CnAβ1 enhances brown adipocyte differentiation and drives metabolic overactivation through FoxO1 activation
2025cited by 0position: contributordoi
Remodeling p38 signaling in muscle controls locomotor activity via IL-15.
2024cited by 14position: contributordoi
MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension
Science Advances 2024cited by 10position: lastdoi
From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk.
2024cited by 9position: contributordoi
MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.
2024cited by 9position: contributordoi
Hepatic nutrient and hormone signaling to mTORC1 instructs the postnatal metabolic zonation of the liver.
2024cited by 8position: contributordoi
DIDO is necessary for the adipogenesis that promotes diet-induced obesity
Proceedings of the National Academy of Sciences 2024cited by 5position: contributordoi
Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.
2024cited by 4position: contributordoi
p38α kinase governs muscle strength through PGC1α in mice.
2024cited by 3position: contributordoi
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent.
2023cited by 21position: contributordoi
Myeloid p38 activation maintains macrophage-liver crosstalk and BAT thermogenesis through IL-12-FGF21 axis.
2023cited by 19position: contributordoi
Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake.
2023cited by 14position: contributordoi
Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation.
2023cited by 6position: contributordoi
Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition.
2023cited by 6position: contributordoi
p38γ/δ activation alters cardiac electrical activity and predisposes to ventricular arrhythmia.
2023cited by 3position: contributordoi
Lack of p38 activation in T cells increases IL-35 production and protects against obesity by promoting thermogenesis
2023cited by 0position: contributordoi
Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21.
2022cited by 51position: contributordoi
Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals.
2022cited by 51position: contributordoi
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
Journal of Hepatology 2022cited by 43position: contributordoi
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
2022cited by 40position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 35 papers (2019–2026)Alfonso Mora · Molecular Oncology (United States)22 papers (2019–2026)Miguel Marcos · Centro de Investigación Biomédica en Red de Cáncer11 papers (2019–2025) · 10 papers (2020–2026)Rafael Romero-Becerra · Cancer Registry of Norway10 papers (2020–2026)Barbara Gonzalez-Teran · Gladstone Institutes7 papers (2020–2023) · 7 papers (2019–2025)Juan Antonio López · Spanish National Centre for Cardiovascular Research7 papers (2019–2024)Roger J. Davis · University of Massachusetts System6 papers (2019–2026)Jesús Vázquez · Autonomous University of Tamaulipas6 papers (2019–2025)Patricia Aspichueta · Centre for Biomedical Network Research on Rare Diseases5 papers (2019–2026)Teresa C. Delgado · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas4 papers (2021–2022) · 4 papers (2023–2025)Marta Varela-Rey · Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas4 papers (2021–2026) · 4 papers (2023–2025)Roger J. Davis · University of Massachusetts Chan Medical School4 papers (2012–2014) · 3 papers (2021–2022)Luis Leiva · Spanish National Cancer Research Centre3 papers (2021–2024)Anxo Vidal · Center for Research in Molecular Medicine and Chronic Diseases3 papers (2019–2026)Alejo Efeyan · Toxicologie, Pharmacologie et Signalisation Cellulaire3 papers (2021–2024)